Nonin Medical Inc announces the publication of two separate studies that demonstrate the clinical efficacy of the company’s EQUANOX Model 7600 cerebral and somatic oximetry system in adult and pediatric patients.
The studies, published in the Annals of Thoracic Surgery (November 2012) and the Journal of Cardiothoracic and Vascular Anesthesia (December 2012), demonstrate the clinical effectiveness of Nonin’s EQUANOX sensors in measuring critical oxygen saturation levels in the brain. According to the company, these studies represent the first published results to demonstrate the absolute accuracy of a near infrared spectroscopy (NIRS) cerebral oximeter system in a wide range of patients. Nonin Medical sponsored the studies.
The EQUANOX system—a NIRS-based monitoring device—noninvasively and continuously detects oxygen saturation status in the brain and other tissue. The device allows clinicians to quickly react to reverse harmful tissue ischemia events before they become critical.
1. Kreeger N, Ramamoorthy C, Nicholson SC, et al. Evaluation of Pediatric Near-Infrared Cerebral Oximeter for Cardiac Disease. Annals of Thoracic Surgery. 2012; 94:1527-33.
2. MacLeod DB, Ikeda K, Vacchiano C, et al. Development and Validation of a Cerebral Oximeter Capable of Absolute Accuracy. Journal of Cardiothoracic and Vascular Anesthesia, 2012 Dec; 26(6):1007-14.
3. Davie SN, Grocott HP. Impact of Extracranial Contamination on Regional Cerebral Oxygen Saturation: A Comparison of Three Cerebral Oximetry Technologies. Anesthesiology. 2012; 116(4):1-7.